The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

MEDICAID CUTS STALL MEGABILL — House Republicans failed to secure enough votes as of Thursday morning for their massive ...

The Opposition has renewed calls to fund the B strain of the meningococcal vaccine after six out of the seven recorded cases ...

Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...

"Vaccines are a safe and effective way that individuals can protect themselves, their families and our community against many ...

The Centers for Disease Control and Prevention (CDC) has adopted new vaccine recommendations that expand protection for respiratory syncytial virus (RSV) and meningococcal disease, backing products ...

GSK is currently the market leader in the meningococcal vaccine market, racking up sales of £1.26 billion (almost $1.6 billion) last year across the Bexsero and Menveo brands, but is having to ...

Armed with new data, GSK is preparing to file for approval of its new-generation meningitis vaccine, as it tries to maintain its leadership in the category against a challenge from Pfizer ...

Good morning, it’s the third of July. This newsletter will be off tomorrow for the holiday and — surprise — all of next week.

The Department of Health and Human Services under Robert F. Kennedy Jr. has taken unprecedented steps to change how vaccines ...